Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure

Heart Failure
Source:

Team

Learn more about the team from BioxyTran

Investors

Learn more about BioxyTran investors and S1 Stocks

Forum

Join the conversation as we discuss Bioxytran's use-cases,
development progress, and more.